MSB 5.24% $1.11 mesoblast limited

Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-127

  1. 120 Posts.
    lightbulb Created with Sketch. 122
    I mentioned in my post on Wednesday about the dire situation in Switzerland and suggested that msb partner with Roche.

    I meant Novartis

    There is a massive swiss market for rem-l and we are now partnering with one company that must have influence. Very significant announcement.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.